Navigation Links
Implanet Using IBM Software to Protect Patients in the Event of Medical Device Recalls

ARMONK, N.Y., Sept. 2 /PRNewswire-FirstCall/ -- Implanet, a manufacturer of implantable medical devices, has selected IBM (NYSE: IBM) sensor technology as the foundation for BeepN'Track, a new service that traces the movement of Implanet's products - including knee and hip implants - across its supply chain to hospitals.

Spiraling medical costs and growing demand for medical care present the health care industry with unprecedented challenges. To meet the cost and quality expectations of the hospitals it serves, Implanet is infusing its operations with new intelligence to reduce the costs associated with human error, out-of-stock products, and supply chain inefficiencies while offering the best possible medical devices and supporting services.

By offering a line of products that are completely traceable, Implanet gives health care providers the peace of mind that comes with being able to easily identify patients whose implanted medical devices are the subject of a recall.

Prior to the creation of its new system, Implanet had no means of tracking its products once they left its manufacturing facilities. This meant the company's medical devices were difficult to trace once shipped.

The company's BeepN'Track service uses Radio Frequency Identification (RFID) tags to track medical devices from Implanet to hospitals. Prior to shipping, Implanet affixes an RFID tag bearing a unique serial number to the packaging of each individual device. Before a surgical procedure takes place, a hospital uses a handheld device to scan the tag from the medical device being implanted and stores that information along with the patient's records. The tag is given to the patient after surgery so he or she will have all available information concerning the implant in the event of future concerns.

The information stored on the tags is gathered by IBM's WebSphere Sensor Events software and transmitted to IBM's InfoSphere Traceability Server software. This allows Implanet to manage and share information with the systems of any trading partners that adhere to GS1 EPCglobal's Electronic Product Code Information Services standard for capturing and sharing sensor data.

"We do not want to focus on our commodity product - the implant itself - but on a complete solution which makes the product smart and thus creates a new generation of medical solutions," said Erick Cloix, chief executive officer, Implanet. "With IBM's health care industry knowledge and its technology expertise, this initiative is opening up the whole international market to us."

IBM is creating a smarter, more connected healthcare system that delivers better care with fewer mistakes, predicts and prevents diseases, and empowers people to make better choices. This includes integrating data so doctors, patients and insurers can share information seamlessly and efficiently. IBM also helps clients apply advanced analytics to improve medical research, diagnosis and treatment in order to improve patient care and help reduce healthcare costs.

About IBM

For more information about IBM, visit:

For more information about IBM sensor technologies, visit:

To see a video on smarter healthcare go to

    Carine Legras
    +33 6 75 65 35 86

    Holli Haswell

    Caroline Dauba de Remur
    + 33 557 995 555

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. American Institute for Plastic Surgery is Using Artefill to Fight Patient Wrinkles
2. Researchers identify protein involved in causing gum disease, osteoporosis, arthritis
3. Summit VetPharm Helps Veterinarians Protect Against Product Diversion, Counterfeiting and Shrinkage Using Vectra(R) Bloodhound(R) Technology
4. Researchers identify new, cancer-causing role for protein
5. Ageless, Time-tested for Enhanced Body Image Using the Color Orange Revealed at Upcoming Women Taking Care of the World Conference in St. Petersburg, FL
6. Business Association in Denver Invites Award-winning Author of ColorAlchemy to Provide Motivation to Energize Performance and Stimulate Success Using the Color Red
7. Argonne, University of Chicago Scientists Develop Targeted Cancer Treatment Using Nanomaterials
8. Argonne, University of Chicago scientists develop targeted cancer treatment using nanomaterials
9. New Antibiotics May Target Cancer-Causing Proteins
10. Goold Health Systems Accelerates Backups by 5-times Using Arkeia Network Backup
11. Confusing New PBM Drug Pricing Terms Leave Payors Unsure of Next Steps
Post Your Comments:
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... On ... as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle ... honor of the city’s history as home to some of the world’s leading providers ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 2016 Bracket , a leading clinical trial ... clinical outcomes platform, Bracket eCOA (SM) 6.0, at the ... – 30, 2016 in Philadelphia , Pennsylvania.  ... Assessment product of its kind to fully integrate with RTSM, ... eCOA 6.0 is a flexible platform for electronic clinical outcomes ...
Breaking Medicine Technology: